Prostate Cancer
Recent Abstracts
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System
November 9, 2023
Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
November 9, 2023
AI-powered radiomics: revolutionizing detection of urologic malignancies.
November 9, 2023
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
November 9, 2023
Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data.
November 9, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.
November 9, 2023
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer
November 8, 2023
De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?
November 8, 2023
Relationship between Eccentricity and Volume Determined by Spectral Algorithms Applied to Spatially Registered Bi-Parametric MRI and Prostate Tumor Aggressiveness: A Pilot Study.
November 8, 2023
Association of Frailty and Complications Following Prostate Biopsy: Results from a Population-Based, Privately Insured Cohort.
November 8, 2023
Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.
November 8, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer.
November 8, 2023
Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer.
November 8, 2023
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges.
November 8, 2023
Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer.
November 8, 2023
Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsyproven radio-recurrent localized prostate cancer.
November 8, 2023
Can MRI Help Inform Which Men with a History of Multifocal High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
November 8, 2023
A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer.
November 8, 2023
Recruitment Target Achieved for Phase II SAR-Bombesin Prostate Cancer Trial
November 7, 2023
Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radioligand Therapy.
November 7, 2023
Page 70 of 1414
Start
Prev
65
66
67
68
69
70
71
72
73
74
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free